title: Neurofibromatosis 2.
abstract: A comprehensive discussion of neurofibromatosis 2 (NF2) is presented, including clinical characteristics, symptoms, diagnosis, tumor types, prevalence and incidence, genetic testing, imaging, treatment options, and follow-up management of NF2.
authors.affiliation: House Clinic, House Research Institute, 2100 West 3rd Street, Suite 111, Los Angeles, CA 90057, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Hoa
authors.forename: William H
authors.initials: WH
authors.lastname: Slattery
mesh_terms: D003390:Cranial Nerve Neoplasms / Q000175:diagnosis / Q000453:epidemiology; D003937:Diagnosis, Differential; D003952:Diagnostic Imaging / Q000379:methods; D005124:Eye Abnormalities / Q000175:diagnosis / Q000453:epidemiology; D005260:Female; D016515:Genes, Neurofibromatosis 2; D020022:Genetic Predisposition to Disease / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D008297:Male; D008579:Meningioma / Q000175:diagnosis / Q000453:epidemiology; D009456:Neurofibromatosis 1 / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D016518:Neurofibromatosis 2 / Q000175:diagnosis* / Q000453:epidemiology* / Q000235:genetics / Q000628:therapy; D009464:Neuroma, Acoustic / Q000175:diagnosis / Q000453:epidemiology; D011379:Prognosis; D018570:Risk Assessment; D013125:Spinal Neoplasms / Q000175:diagnosis / Q000453:epidemiology; D016019:Survival Analysis